Real‐world multicentre observational study of effectiveness and toxicity in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab

Documenti analoghi

• Efficacy and safety of cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma: A multicentre real‐world retrospective study from Spain and systematic review of the published data
  di: J. Cañueto, et al.
  Pubblicazione: (2024)
• EADO classification of difficult‐to‐treat cutaneous squamous cell carcinoma in transplant recipients
  di: Javier Lara‐Trigo, et al.
  Pubblicazione: (2026)
• Excellent response to cemiplimab and radiotherapy in advanced metastatic porocarcinoma
  di: Nessr Abu Rached, et al.
  Pubblicazione: (2024)
• Operational classification of cutaneous squamous cell carcinomas based on unsupervised clustering of real cases by experts
  di: C. Gaudy‐Marqueste, et al.
  Pubblicazione: (2024)
• Histological deep margins in cutaneous squamous cell carcinoma of the scalp and risk of recurrence
  di: Júlia Verdaguer‐Faja, et al.
  Pubblicazione: (2024)